Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price was up 6.2% on Monday . The company traded as high as $1.73 and last traded at $1.72. Approximately 9,731,177 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 25,240,365 shares. The stock had previously closed at $1.62.
Tilray Price Performance
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The stock’s 50 day simple moving average is $1.82 and its 200 day simple moving average is $1.87. The firm has a market capitalization of $1.45 billion, a P/E ratio of -3.83 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last issued its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same period last year, the business earned ($0.15) EPS. The company’s revenue for the quarter was up 24.8% on a year-over-year basis. As a group, analysts expect that Tilray Inc will post -0.12 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
- Five stocks we like better than Tilray
- Golden Cross Stocks: Pattern, Examples and Charts
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Insider Selling Explained: Can it Inform Your Investing Choices?
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- With Risk Tolerance, One Size Does Not Fit All
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.